⌘K

Login Start Free

Home/Filings/4/0000950170-25-032730

4//SEC Filing

Hunt Hazel 4

Accession 0000950170-25-032730

CIK 0001088856other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 7:38 PM ET

Size

5.4 KB

Accession

0000950170-25-032730

Insider Transaction Report

Form 4

Period: 2025-02-28

CORCEPT THERAPEUTICS INCCORT

Chief Scientific Officer

Transactions

Award
Stock Option (right to buy)
2025-02-28+140,000→ 140,000 total
Exercise: $60.58Exp: 2035-02-28→ Common Stock (140,000 underlying)

Footnotes (1)

[F1]Exercise ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

CORCEPT THERAPEUTICS INC

CIK 0001088856

Entity typeother

Related Parties

1

filerCIK 0001698307

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 7:38 PM ET
Size: 5.4 KB

View on SEC.gov